Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Author Archives: Warren Woessner
BIO’s Modest Proposal – Eliminate Rule 56
BIO recently sent Director Kappos 13 pages of comments on the PTO’s proposed revisions to 37 C.F.R. §1.56(b). (A copy of the comments is available at the end of this post.) BIO clearly is struggling to reconcile the differing views … Continue reading
Biotech IP Newsletters
Find below biotech IP newsletters recently provided by Dr. Stefan Danner. SPCs For Combination Products – Opinion Of The Advocate General EPO Ruling On The Patentability Of Medical Treatments By Therapy
Posted in Non-U.S. Practice
Tagged Dr. Stefan Danner, EPO, intellectual property, Patent Law, Warren Woessner
Leave a comment
Intensive Patent Law Training Seminar
Course Announcement: Intensive Patent Law Training Seminar February 22-24, 2012 New York City The Chisum Patent Academy is pleased to accept registrations for our next seminar, to be held on February 22-24, 2012 in New York City. Our venue is … Continue reading
Posted in Conferences and Classes
Tagged intellectual property, ip, IP law tools, Patent Law, patents
Leave a comment
HUMAN GENOME SCIENCES v. ELI LILLY – Increased European Harmony?
By Paul Cole, European Patent Attorney, Lucas & Co – Warlingham, UK Judgement – Human Genome Sciences Inc (Appellant) v Eli Lilly and Company (Respondent) The above proceedings relate to European Patent (UK) 0,939,804 concerning a new human protein called Neutrokine-α. … Continue reading
Posted in EP and UK Practice
Tagged court of appeals, Eli Lilly, EPO, Patent Law, Paul Cole, Supreme Court, Warren Woessner
1 Comment